Gossamer Bio, Inc. (GOSS)
9.31
-0.57
(-5.77%)
USD |
NASDAQ |
Oct 09, 16:00
9.29
-0.02
(-0.21%)
After-Hours: 20:00
Gossamer Bio Cash and Short Term Investments (Quarterly) : 57.03M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 57.03M |
| March 31, 2026 | 99.22M |
| December 31, 2025 | 136.93M |
| September 30, 2025 | 180.22M |
| June 30, 2025 | 212.92M |
| March 31, 2025 | 257.93M |
| December 31, 2024 | 294.52M |
| September 30, 2024 | 327.03M |
| June 30, 2024 | 354.49M |
| March 31, 2024 | 244.39M |
| December 31, 2023 | 296.42M |
| September 30, 2023 | 328.89M |
| June 30, 2023 | 162.13M |
| March 31, 2023 | 201.86M |
| December 31, 2022 | 255.68M |
| September 30, 2022 | 304.38M |
| June 30, 2022 | 222.16M |
| March 31, 2022 | 271.69M |
| Date | Value |
|---|---|
| December 31, 2021 | 325.28M |
| September 30, 2021 | 366.08M |
| June 30, 2021 | 406.48M |
| March 31, 2021 | 453.86M |
| December 31, 2020 | 513.19M |
| September 30, 2020 | 555.38M |
| June 30, 2020 | 600.36M |
| March 31, 2020 | 346.16M |
| December 31, 2019 | 401.83M |
| September 30, 2019 | 446.47M |
| June 30, 2019 | 464.00M |
| March 31, 2019 | 481.22M |
| December 31, 2018 | 228.86M |
| September 30, 2018 | 256.64M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.315M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| United Therapeutics Corp. | 2.662B |
| Arbutus Biopharma Corp. | 92.62M |
| Kura Oncology, Inc. | 519.02M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |